The latest report from SDi examines the bioprocessing market which they project will grow at a compound annual growth rate (CAGR) of 9.0% during the next five years. The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. […]

In the first article of our series, we discussed the most important trends within the bioprocessing industry: continuous processing, single-use technology, and improving process productivity. These goals have become increasingly important as the bioprocessing industry has quickly become a competitive field due to demand of biosimilars and expanding development and regulatory approval of biologics-based therapeutics.